Sapanisertib
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for Sapanisertib, covering 2017-03-27 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial [Phase 1, Phase 2]